Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes

被引:113
|
作者
Swiryn, Steven [1 ]
Orlov, Michael V. [2 ]
Benditt, David G. [3 ]
DiMarco, John P. [4 ]
Lloyd-Jones, Donald M. [1 ]
Karst, Edward [5 ]
Qu, Fujian [5 ]
Slawsky, Mara T. [6 ]
Turkel, Melanie [5 ]
Waldo, Albert L. [7 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Tufts Univ, Sch Med, Boston, MA 02111 USA
[3] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[4] Univ Virginia, Charlottesville, VA USA
[5] St Jude Med, Sunnyvale, CA USA
[6] Tufts Univ, Sch Med, Baystate Med Ctr, Springfield, MA 01199 USA
[7] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA
关键词
anti-coagulation; atrial fibrillation; defibrillators; pacemakers; stroke; trials; TEMPORAL RELATIONSHIP; RISK-FACTOR; STROKE; EVENTS; DURATION;
D O I
10.1161/CIRCULATIONAHA.115.020252
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The RATE Registry (Registry of Atrial Tachycardia and Atrial Fibrillation Episodes) is a prospective, outcomes-oriented registry designed to document the prevalence of atrial tachycardia and/or fibrillation (AT/AF) of any duration in patients with pacemakers and implantable cardioverter defibrillators (ICDs) and evaluate associations between rigorously adjudicated AT/AF and predefined clinical events, including stroke. The appropriate clinical response to brief episodes of AT/AF remains unclear. Methods: Rigorously adjudicated electrogram (EGM) data were correlated with adjudicated clinical events with logistic regression and Cox models. Long episodes of AT/AF were defined as episodes in which the onset and/or offset of AT/AF was not present within a single EGM recording. Short episodes of AT/AF were defined as episodes in which both the onset and offset of AT/AF were present within a single EGM recording. Results: We enrolled 5379 patients with pacemakers (N=3141) or ICDs (N=2238) at 225 US sites (median follow-up 22.9 months). There were 359 deaths. There were 478 hospitalizations among 342 patients for clinical events. We adjudicated 37531 EGMs; 50% of patients had at least one episode of AT/AF. Patients with clinical events were more likely than those without to have long AT/AF (31.9% vs. 22.1% for pacemaker patients and 28.7% vs. 20.2% for ICD patients; P<0.05 for both groups). Only short episodes of AT/AF were documented in 9% of pacemaker patients and 16% of ICD patients. Patients with clinical events were no more likely than those without to have short AT/AF (5.1% vs. 7.9% for pacemaker patients and 11.5% vs. 10.4% for ICD patients; P=0.21 and 0.66, respectively). Conclusions: In the RATE Registry, rigorously adjudicated short episodes of AT/AF, as defined, were not associated with increased risk of clinical events compared with patients without documented AT/AF. Clinical Trial Registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00837798.
引用
收藏
页码:1130 / 1140
页数:11
相关论文
共 50 条
  • [41] Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke
    Al-Gibbawi, Mounir
    Ayinde, Hakeem O.
    Bhatia, Neal K.
    El-Chami, Mikhael F.
    Westerman, Stacy B.
    Leon, Angel R.
    Shah, Anand D.
    Patel, Anshul M.
    De Lurgio, David B.
    Tompkins, Christine M.
    Lloyd, Michael S.
    Merchant, Faisal M.
    Kiani, Soroosh
    HEART RHYTHM, 2021, 18 (03) : 338 - 346
  • [42] Device-detected atrial sensing amplitudes as a marker of increased risk for new onset and progression of atrial high-rate episodes
    Biffi, Mauro
    Celentano, Eduardo
    Giammaria, Massimo
    Curnis, Antonio
    Rovaris, Giovanni
    Ziacchi, Matteo
    Miracapillo, Gennaro
    Saporito, Davide
    Baroni, Matteo
    Quartieri, Fabio
    Marini, Massimiliano
    Pepi, Patrizia
    Senatore, Gaetano
    Caravati, Fabrizio
    Calvi, Valeria
    Tomasi, Luca
    Nigro, Gerardo
    Bontempi, Luca
    Notarangelo, Francesca
    Santobuono, Vincenzo Ezio
    Boggian, Giulio
    Arena, Giuseppe
    Solimene, Francesco
    Giaccardi, Marzia
    Maglia, Giampiero
    Perini, Alessandro Paoletti
    Volpicelli, Mario
    Giacopelli, Daniele
    Gargaro, Alessio
    Iacopino, Saverio
    HEART RHYTHM, 2024, 21 (09) : 1630 - 1639
  • [43] Clinical Predictors of Device-Detected Atrial Fibrillation During 2.5 Years After Cardiac Surgery Prospective RACE V Cohort
    Gilbers, Martijn D.
    Kawczynski, Michal J.
    Bidar, Elham
    Maesen, Bart
    Isaacs, Aaron
    Winters, Joris
    Linz, Dominik
    Rienstra, Michiel
    van Gelder, Isabelle
    Maessen, Jos G.
    Schotten, Ulrich
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2024, 10 (05) : 941 - 955
  • [44] Wearable Cardiac Rhythm Monitoring Device for Detection of Postoperative Atrial Fibrillation
    Hibino, Makoto
    Pandey, Arjun K.
    Verma, Subodh
    Puar, Pankaj
    Teoh, Hwee
    Quan, Adrian
    Verma, Raj
    Yau, Terrence M.
    Bisleri, Gianluigi
    Yanagawa, Bobby
    Mazer, David
    Verma, Atul
    Ha, Andrew C. T.
    ANNALS OF THORACIC SURGERY, 2023, 116 (04): : 854 - 858
  • [45] Cardiac implantable electronic device-detected atrial fibrillation-"To anticoagulate or not to anticoagulate, that is the question": The noble or ignoble choice?
    Deering, Thomas F.
    Zannad, Faiez
    HEART RHYTHM, 2021, 18 (03) : 347 - 348
  • [46] Relationship between device-detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator
    Arai, Shuhei
    Kawamura, Mitsuharu
    Gokan, Toshihiko
    Yoshikawa, Kosuke
    Ogawa, Ko
    Ochi, Akinori
    Munetsugu, Yumi
    Ito, Hiroyuki
    Shinke, Toshiro
    CLINICAL CARDIOLOGY, 2020, 43 (12) : 1517 - 1523
  • [47] Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: assessing net clinical benefit
    McIntyre, William F.
    Benz, Alexander P.
    Tojaga, Nedim
    Brandes, Axel
    Lopes, Renato D.
    Healey, Jeff S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2024, 26 : iv4 - iv11
  • [48] Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis
    Mahajan, Rajiv
    Perera, Tharani
    Elliott, Adrian D.
    Twomey, Darragh J.
    Kumar, Sharath
    Munwar, Dian A.
    Khokhar, Kashif B.
    Thiyagarajah, Anand
    Middeldorp, Melissa E.
    Nalliah, Chrishan J.
    Hendriks, Jeroen M. L.
    Kalman, Jonathan M.
    Lau, Dennis H.
    Sanders, Prashanthan
    EUROPEAN HEART JOURNAL, 2018, 39 (16) : 1407 - 1415
  • [49] The influence of symptoms and device detected atrial tachyarrhythmias on medical management: Insights from A-HIRATE
    Ghali, Jalal K.
    Orlov, Michael V.
    Araghi-Niknam, Mohsen
    Sherfesee, Lou
    Hettrick, Douglas A.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2007, 30 (07): : 850 - 857
  • [50] Progression of Device-Detected Atrial High-Rate Episodes and the Risk of All-Cause Mortality
    Jiang, Jiang
    Sun, Xuerong
    Cheng, Chendi
    Chen, Keping
    Hua, Wei
    Su, Yangang
    Xu, Wei
    Chen, Ruohan
    Zhang, Shu
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 204 : 96 - 103